If Management are to retain even a modicum of the dwindling amount of trust that investors have in them, they are going to have to be a little more forthcoming and less delphic in the information which they release to the public. At the ASM they are going to have to give the meeting something tangible and I would hope that this message is given to them.
In an "ordinary" company Management couldn't get away with such a tight-lipped policy as now exists in NWBO. However, NWBO's Management have established so tight a control of the company (thanks to the rapacious way in which they have built up their control at the expense of the small investor) that they no longer need the supoport of the company's shareholders outside their own clique.
Again it all comes down to how Management can be persuaded to be somewhat forthcoming with information which isn't sensitive. For example, we are told by some on this board that there may have been approaches already by big Pharma but nothing has been reported publically. Why not?? On the principle of "No names, no pack-drill" there can be absolutely nothing harmful to the company for such information to be released as long as the potential suitor is not named. If there were inded a suitor, news of the approach would certainly start other companies wondering whether they should make an approach before it is too late. Of course, there may not have been any approaches but who would know thanks to the policy of keeping us all in the dark.
At the ASM, perhaps somebody could ask of Management what exactly are the conditions which will trigger the unblinding of the trial. We should all then be able to keep our collective eyes open for when those trigger points are reached and can make more reasonable deductions as to what a failure to announce the unblinding really means.
If Management can't / won't provide that information and refuses to explain why, it will be perhaps the final nail in this company's coffin should that date arrive and nothing happens. I have no doubt that will drive the SP even further lower, even to bankruptcy, aided by the sudden influx onto the market of genuine shares being sold by genuine long-term holders.
Are you reading this, Management?
